Basic tumor research column

KHSRP regulates the responsiveness of prostate cancer cells to androgens through ANK3

  • CAI Renjie ,
  • XU Ming
Expand
  • Department of Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201999, China
XU Ming, E-mail: mingxu@shsmu.edu.cn.

Received date: 2023-10-30

  Accepted date: 2024-02-18

  Online published: 2024-04-28

Supported by

National Natural Science Foundation of China(81302236)

Abstract

Objective ·To investigate the impact of KH-type splicing regulatory protein (KHSRP) on the proliferation of prostate cancer cells and the regulation of downstream gene expression, and explore the potential role and mechanism of KHSRP in the transition of prostate cancer from androgen-dependent to androgen-independent. Methods ·Recombinant lentivirus was used to infect androgen-dependent prostate cancer LNCaP cells and androgen-independent prostate cancer DU145 cells to establish stable cell lines with functional deficiency/acquisition of KHSRP, and the functional differences of KHSRP between the two cell types were compared. Western blotting was used to detect the expression levels of KHSRP, androgen receptor (AR), and ankyrin 3 (ANK3) in the stable cell lines. Cell proliferation assay, colony formation assay, and mouse xenograft assay were performed to assess the impact of KHSRP on the proliferation ability of LNCaP cells. RNA sequencing (RNA-seq) was performed to identify downstream genes affected by KHSRP, and the mRNA expression levels of these genes were measured by quantitative real-time PCR (RT-qPCR). The expression of ANK3 and KHSRP in prostate tissue samples and the difference of ANK3 expression in different prostate cancer cell lines were analyzed by combining Cancer Cell Line Encyclopedia (CCLE), The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Results ·GEO data analysis showed that KHSRP was upregulated in prostate cancer tissues compared to benign prostate tissues, suggesting its association with prostate tumorigenesis. Cell proliferation assay, colony formation assay, and mouse xenograft assay demonstrated a negative correlation between KHSRP expression and the proliferation ability of LNCaP cells, indicating that KHSRP can inhibit the proliferation of prostate cancer cells, with a stronger effect on LNCaP cells than on DU145 cells. Western blotting and RT-qPCR analysis of the stable LNCaP cell lines showed that KHSRP overexpression led to a decrease in AR protein level without affecting its mRNA level, suggesting that KHSRP can indirectly regulate AR protein level. RNA-seq and RT-qPCR results showed KHSRP was positively correlated with the expression of ANK3, a regulatory factor affecting AR protein stability, and subsequent Western blotting confirmed an increase in ANK3 protein expression after KHSRP overexpression. TCGA data analysis further supported the correlation between KHSRP and ANK3 mRNA expression. Interestingly, according to CCLE and GEO data, the expression of ANK3 was closely related to prostate cancer malignancy. Conclusion ·KHSRP may indirectly regulate AR protein stability through ANK3, thereby influencing the proliferation of androgen-dependent prostate cancer cells and mediating the altered responsiveness to androgen in prostate cancer cells.

Cite this article

CAI Renjie , XU Ming . KHSRP regulates the responsiveness of prostate cancer cells to androgens through ANK3[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(4) : 417 -426 . DOI: 10.3969/j.issn.1674-8115.2024.04.001

References

1 SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
2 DESAI K, MCMANUS J M, SHARIFI N. Hormonal therapy for prostate cancer[J]. Endocr Rev, 2021, 42(3): 354-373.
3 ROSSI M, BUCCI G, RIZZOTTO D, et al. LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β[J]. Nat Commun, 2019, 10(1): 1969.
4 YUAN H H, DENG R, ZHAO X, et al. SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis[J]. Mol Cancer, 2017, 16(1): 157.
5 LU W M, WANG Q, XU C, et al. SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma[J]. Neoplasia, 2021, 23(1): 129-139.
6 WANG T T, ABOU-OUF H, HEGAZY S A, et al. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients[J]. J Mol Med, 2016, 94(12): 1411-1422.
7 POLKINGHORN W R, PARKER J S, LEE M X, et al. Androgen receptor signaling regulates DNA repair in prostate cancers[J]. Cancer Discov, 2013, 3(11): 1245-1253.
8 CHENG C, CAI Y X, LIU X W, et al. KHSRP modulated cell proliferation and cell cycle via regulating PPP2CA and p27 expression in Wilms tumor[J]. Cell Signal, 2022, 100: 110447.
9 XU J Y, WANG D S, MA H L, et al. KHSRP combines transcriptional and posttranscriptional mechanisms to regulate monocytic differentiation[J]. Blood Sci, 2022, 4(3): 103-115.
10 RAMDZAN Z M, NEPVEU A. CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers[J]. Nat Rev Cancer, 2014, 14: 673-682.
11 REBELLO R J, OING C, KNUDSEN K E, et al. Prostate cancer[J]. Nat Rev Dis Primers, 2021, 7: 9.
12 NARITA S, NOMURA K, HATAKEYAMA S, et al. Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer[J]. Sci Rep, 2019, 9(1): 12071.
13 LABAF M, LI M Q, TING L, et al. Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2[J]. Front Oncol, 2022, 12: 1021845.
14 KUROZUMI S, JOSEPH C, RAAFAT S, et al. Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer[J]. Breast Cancer Res Treat, 2019, 176(1): 63-73.
Outlines

/